Enhanced Recovery After Surgery Impact on the Systemic Inflammatory Response of Patients Following Gynecological Oncology Surgery: A Prospective Randomized Study
Jin Peng,Ruiying Dong,Jianfen Jiao,Min Liu,Xi Zhang,Hualei Bu,Ping Dong,Shasha Zhao,Naidong Xing,Shuai Feng,Xingsheng Yang,Beihua Kong
DOI: https://doi.org/10.2147/CMAR.S294718
2021-06-02
Cancer Management and Research
Abstract:Jin Peng, 1 Ruiying Dong, 1 Jianfen Jiao, 1 Min Liu, 1 Xi Zhang, 1 Hualei Bu, 1 Ping Dong, 2 Shasha Zhao, 3 Naidong Xing, 4 Shuai Feng, 5 Xingsheng Yang, 1 Beihua Kong 1 1 Department of Obstetrics and Gynecology, Qilu hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China; 2 Department of Anesthesiology, Qilu Hospital, Shandong University, Jinan, People's Republic of China; 3 Department of Clinical Nutrition, Qilu Hospital, Shandong University, Jinan, People's Republic of China; 4 Department of Urology, Qilu Hospital, Shandong University, Jinan, People's Republic of China; 5 Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, People's Republic of China Correspondence: Xingsheng Yang Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, No. 107 West Wenhua Road, Jinan, 250001, People's Republic of China Email Objective: Enhanced recovery after surgery (ERAS) protocol has widely gained acceptance in gynecological surgery. Its safety and efficacy should be evaluated fully via well-designed, randomized, control trials. The main objective of our study is to compare the ERAS protocol with the conventional perioperative care program after gynecological oncology. Furthermore, the secondary objectives of our study are the identification of markers that allow us to evaluate the effectiveness of the application of ERAS elements in the modulation of the body's response to surgical stress. Methods: Patients with gynecological tumors indicated for surgery were randomly assigned to either the ERAS group or the conventional group. The ERAS protocol included short fasting time, fluid restriction, early oral feeding, reduced opioid consumption and immediate mobilization after surgery. The primary endpoint was the reduction of hospital stay in the ERAS group. The day of first flatus, postoperative nausea and vomiting (PONV), maximum pain score by the visual analogue scale (VAS) and complication, readmission rate, reoperation rate, postoperative mortality, total hospital cost and systemic inflammatory response (SIR) were secondary endpoints. Results: A total of 130 patients in gynecological tumor surgery were enrolled (ERAS = 65, conventional = 65). The ERAS group had faster bowel function recovery, significantly less pain, less PONV, shorter hospital stay, and less total hospital costs. SIR markers were estimated and screened out that postoperative platelet, neutrophil-lymphocyte-ratio (NLR) and platelet-lymphocyte-ratio (PLR) were significantly lower in ERAS groups compared to conventional groups. Conclusion: The implementation of ERAS protocol is safe and enhances postoperative recovery after gynecological oncology surgery. We firstly reveal the beneficial effect of ERAS protocols on the alleviation of postoperative SIR, which is a reflection of the magnitude of surgical trauma. Postoperative platelet, NLR or PLR could be the novel and inexpensive markers to assess how ERAS protocols modulate gynecological oncology surgery. Trial Registration: The trial was registered in ClinicalTrials.gov (NCT03629626). Keywords: ERAS, enhanced recovery after surgery, systemic inflammatory response, gynecological oncology surgery, NLR, neutrophil-lymphocyte-ratio, PLR, platelet-lymphocyte-ratio Enhanced recovery after surgery (ERAS), which is known as fast-track surgery, is a multimodal, multidisciplinary and evidence-based approach to improving perioperative care of surgical patients to enhance the quality of recovery after surgery by adopting a series of optimized protocols. Initial studies into enhanced recovery were mainly performed in patients undergoing colorectal surgery, but ERAS is now used in many different surgical specialties and procedures. There are consensus guidelines from the ERAS society for patients undergoing gastrointestinal surgery, urological surgery, colorectal surgery, hepatobiliary, pancreatic surgery and gynecological surgery. 1–7 These guidelines have resulted in the widespread acceptance of the ERAS principles. ERAS protocols for diverse surgery types have successfully improved patient outcomes, including decreased postoperative nausea and vomiting (PONV), and decreased length of hospital stay through implementation of several evidence-based procedures, including a preoperative counseling; carbohydrate drinks 2 hours before operation and oral feeding; a standardized approach in anesthetic management and reduced o -Abstract Truncated-
oncology